In the present study, we demonstrated that bitter apricot kernel is indispensable for the in vivo efficacy of XCD in mitigating viral pneumonia, as its removal abrogated the formula’s ability to reduce the lung index, alleviate hemorrhage and edema, and suppress IL-6 transcription. The gene discussed is IL6; the disease is viral pneumonia.